ESMO-MCBS achieved highest rating

Novartis’ Pluvicto Receives Highest Clinical Benefit Score from ESMO for Advanced Prostate Cancer Novartis announced that its Pluvicto (lutetium (177Lu) vipivotide tetraxetan) has received the highest possible score of 5 …